APTAMER SCIENCES INC

News Aptamer Sciences Inc

Equities

A291650

KR7291650000

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
2,770 ^KRW	-1.95%		-2.29%	-23.16%

Mar. 26	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	Mar. 25	CI
Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	22-10-05	CI
Aptamer Sciences Inc announced that it expects to receive KRW 16.5 billion in funding from a group of investors	22-10-03	CI
Aptamer Sciences Inc(KOSDAQ:A291650) dropped from S&P Global BMI Index	22-09-19	CI
Aptamer Sciences Inc.(KOSDAQ:A291650) added to S&P Global BMI Index	21-03-22	CI
Aptamer Sciences Inc. has completed an IPO in the amount of KRW 32.5 billion.	20-09-11	CI
Aptamer Sciences Inc. has filed an IPO.	20-05-25	CI
Aptamer Sciences Inc. has withdrawn its IPO in the amount of KRW 23.4 billion.	20-03-26	CI
Aptamer Sciences Inc. has filed an IPO.	19-11-11	CI
Aptamer Sciences, Inc. announced that it expects to receive $7.3 million in funding	16-06-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
A291650 Stock
News Aptamer Sciences Inc

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW